Software

AI for digital pathology and spatial biology

Katana Labs GmbH

Katana Labs is revolutionizing image-based analysis of tumor tissues using artificial intelligence. Its cloud-based platform PAIKON enables pathologists to visualize and analyse upto a million cells in giga-pixel histopathology images with ease. PAIKON assists in the assessment of multiple cancer entities across various image modalities, enabling the next step in precision medicine.

Katana Labs provides products and services for clinical diagnostics and R&D in the biotech and pharmaceutical industries. Building on expertise in digital pathology, image analysis and AI, the company provides the best algorithms for routine diagnostic tests and facilitates analysis in Spatial Omics for the development of new biomarkers.

TGFS has been involved with the company since 2023.

Status
Active

Segment
Early stage

Headquarter
Dresden

Website
www.katana-labs.com

TGFS-Team
Sarah Schäfer
Martin Liebsch

Company news

New in the portfolio: Katana Labs GmbH

8. Nov. 2023

On the trail of cancer — the software from Katana Labs uses artificial intelligence to detect cancer cells. The TGFS invested in the Dresden-based company in the pre-seed phase so that the analysis software can be further developed, certified and used in laboratories worldwide.